BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Editorial
Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B 
Konstantinos Tziomalos 
World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91
Guidelines For Basic Science
Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma 
Yu-Jing Zhang 
World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94
Guidelines For Clinical Practice
Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib 
Camillo Porta, Chiara Paglino 
World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Review
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma 
Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli 
World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114
Brief Article
Proteomic analysis for developing new biomarkers of hepatocellular carcinoma 
Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata 
World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127
Case Report
Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination 
Sudeep Tanwar, Mark Thursz 
World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136